Stocks

Alexion, Pfizer Rise Premarket; Novartis Falls

© Reuters.

By Peter Nurse 

Investing.com — Stocks in focus in premarket trade on Monday, December 14th. Please refresh for updates.

  • Alexion (NASDAQ:) stock soared 31% after AstraZeneca (NASDAQ:), down 5.6%, bid $39 billion for the U.S. biotech firm, the company’s largest ever and one of this year’s biggest mergers globally.

  • Pfizer (NYSE:) stock rose 1.3% as the pharma giant’s Covid-19 vaccine is rolled out to the U.S. population, starting this week.

  • Novartis (NYSE:) ADR fell 0.9% after the Swiss pharma company said that phase 3 of its Covid-19 treatment didn’t meet its primary objective of reducing the number of hospitalized patients.

  • Tesla (NASDAQ:) stock rose 1.4% with the electric carmaker set to join the benchmark on Friday, prompting index funds to adjust their holdings.

  • Electronic Arts (NASDAQ:) stock rose 2.2% after the games maker reached an agreement on Monday to buy racing game developer Codemasters in a deal worth $1.2 billion.

  • SolarWinds (NYSE:) stock fell 10% after the IT company said it may have been hit in a “highly-sophisticated, targeted and manual supply chain attack by a nation state.”

  • Snowflake (NYSE:) stock rose 1.1% ahead of Tuesday’s first opportunity for company insiders to cash out since the initial public offering three months ago.

  • Alphabet (NASDAQ:) stock fell 0.4% after many of the company’s services, including YouTube, Gmail and Google Drive, were down for thousands of users across the globe on Monday.

  • CureVac (NASDAQ:) stock rose 6.7% after the biotech enrolled its first participant in a clinical trial for its Covid-19 vaccine candidate. CureVac said the study is expected to include more than 35,000 people in Europe and Latin America.
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Most Related Links :
Business News Governmental News Finance News

Need Your Help Today. Your $1 can change life.

[charitable_donation_form campaign_id=57167]

Source link

Back to top button